THEON Therapeutics
Boston, US · Founded 2020 · Delaware corporation
Founders & leadership
NK
Nicholas K. DavisNamed on SEC filing
DS
Donna SeeNamed on SEC filing
LC
Lee CooperNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 2 rounds · 2021–2022
▶$2.9MraisedAug 2022 · 4 investors · OtherRule 506(b)
▶$2.9MraisedAug 2022 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lee CooperDirector
- Neil WhiteDirector
- Jennifer PetterDirector
- Nicholas K. DavisExecutive Officer, Director
- Donna SeeDirector
- Offering amount
- $14.5M
- Amount sold
- $2.9M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.8MraisedFeb 2021 · 4 investors · BiotechnologyRule 506(b)
▶$2.8MraisedFeb 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas K. DavisExecutive Officer, Director
- Donna SeeDirector
- Lee CooperDirector
- Offering amount
- $10M
- Amount sold
- $2.8M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has THEON Therapeutics raised?
- THEON Therapeutics has disclosed $5.7M raised across 2 rounds.
- Where is THEON Therapeutics headquartered?
- THEON Therapeutics is headquartered in Boston, US.